ORIGINAL RESEARCH
Published on 20 May 2025
B and T lymphocyte attenuator (BTLA) and PD-1 pathway dual blockade promotes antitumor immune responses by reversing CD8+ T-cell exhaustion in non-small cell lung cancer
doi 10.3389/fimmu.2025.1553042
- 362 views